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E4-binding protein 4 (E4bp4) was initially iso-
lated by its ability to recognize the proximal 
activating  transcription  factor  binding  site  of 
the adenovirus E4 promoter (Cowell et al., 
1992). Subsequently, E4bp4 was independently 
identified as nuclear factor IL-3 (Nfil3), a pro-
tein expressed in T cells that binds to the 5 
flanking region of the human IL-3 promoter 
(Zhang et al., 1995).
Nfil3 shares sequence identity in its basic 
DNA-binding domain with members of the 
proline- and acidic amino acid–rich (PAR) sub-
family of mammalian bZIP (basic region leu-
cine  zipper)  transcription  factors,  a  subfamily 
that includes HLF (hepatic leukemia factor; 
Ishida et al., 2000), DBP (albumin gene promoter 
D-box binding protein; Mueller et al., 1990), 
and TEF (thyrotroph embryonic factor; Drolet 
et al., 1991). Structurally, the PAR bZIP factors 
are closely related to CES-2, a neuron-specific 
cell death specification protein in the nematode 
Caenorhabditis elegans (Metzstein et al., 1996). 
This similarity implies that mammalian PAR pro-
teins may be involved in cell fate commitment. 
Indeed, we have previously demonstrated that 
both E2A-HLF (Inaba et al., 1992) and Nfil3 
play critical roles in the regulation of apoptosis 
in mammalian pro–B lymphocytes (Ikushima 
et al., 1997; Kuribara et al., 1999). In the murine 
pro–B cell lines Baf-3 and FL5.12, Nfil3 is a 
delayed-early IL-3–responsive gene whose ex-
pression depends on de novo protein synthesis. 
Moreover, in these IL-3–dependent pro–B 
cells, enforced expression of human Nfil3 com-
plementary DNA (cDNA) promotes cell survival, 
indicating that Nfil3 induction is a mechanism 
by which IL-3 suppresses apoptosis (Ikushima 
et al., 1997).
Since the publication of these findings, Nfil3 
has been implicated in a diverse range of pro-
cesses, including the antiinflammatory response 
(Wallace et al., 1997), intracellular signal trans-
duction (Kuribara et al., 1999), and the mam-
malian circadian oscillatory mechanism (Mitsui 
et al., 2001; Ohno et al., 2007). The plethora 
of regulatory pathways that impinge on Nfil3, 
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Nuclear factor interleukin-3 (Nfil3; also known as E4-binding protein 4) is a basic region 
leucine zipper transcription factor that has antiapoptotic activity in vitro under conditions of 
growth factor withdrawal. To study the role of Nfil3 in vivo, we generated gene-targeted 
Nfil3-deficient (Nfil3/) mice. Nfil3/ mice were born at normal Mendelian frequency and 
were grossly normal and fertile. Although numbers of T cells, B cells, and natural killer (NK)  
T cells were normal in Nfil3/ mice, a specific disruption in NK cell development resulted in 
severely reduced numbers of mature NK cells in the periphery. This defect was NK cell intrin-
sic in nature, leading to a failure to reject MHC class I–deficient cells in vivo and reductions 
in both interferon  production and cytolytic activity in vitro. Our results confirm the spe-
cific and essential requirement of Nfil3 for the development of cells of the NK lineage.
© 2009 Kamizono et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.jem.org/misc/terms.shtml). After six 
months it is available under a Creative Commons License (Attribution–Noncom-
mercial–Share Alike 3.0 Unported license, as described at http://creativecommons 
.org/licenses/by-nc-sa/3.0/).
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Nfil3 by IL-3 in BM-derived mast cells was used as a positive 
control (Fig. S2 A, top). Analysis of Nfil3 expression levels in 
NK, NK T, and CD3+ T cells purified from BM revealed 
higher levels of Nfil3 in mNK cells (CD3CD122+NK1.1+) 
than in CD3+ T cells (Fig. S2 A, bottom).
Previous studies using in situ hybridization in mouse brain 
have demonstrated significant Nfil3 mRNA expression in the 
suprachiasmatic nucleus, hippocampus, gyrus dentatus, and 
piriform cortex (Mitsui et al., 2001). In our hands, X-Gal 
staining of brain tissues from Nfil3+/-IRES -geo mice re-
vealed a similar pattern of Nfil3 expression. Purkinje cells in 
the cerebellum showed prominent X-Gal staining of their 
complete cell bodies and dendrites (Fig.S2, B and C), as did 
the hippocampus, dentate, and cingular gyri (Fig. S2 D) and 
the olfactory bulbs and olfactory tract (not depicted). Other 
tissues that stained strongly positive with X-Gal included 
  skeletal and smooth muscle, as evident in the longitudinal and 
circular muscle layers in the bowel wall (Fig. S2 E), the periph-
eral lobular cells of the liver (Fig. S2 F), and the medulla (but 
not the cortex) of the kidney (Fig. S2 G). Tissues weakly posi-
tive for X-Gal staining and, thus, Nfil3 expression included 
the testis (sperm), salivary glands, and the islets (but not the 
exocrine portion) of the pancreas (unpublished data).
mNK cells are specifically and markedly decreased  
in Nfil3/ mice
We next examined the consequences of an absence of Nfil3 
on the immune system. Consistent with our finding of very 
low Nfil3 expression in total spleen and isolated pure T and B 
cells, gross hematological analysis showed no significant dif-
ferences between WT and Nfil3/ mice in circulating 
blood cell counts, total T and B cell numbers, and T and B 
cell subsets in lymphoid organs (Table I). T and B cell acti-
vation and proliferation in vitro were also normal in the 
absence of Nfil3 (Fig. S3). Strikingly, however, both the   
percentages and absolute numbers of mNK cells (defined as 
NK1.1+CD3 or CD122+DX5+) in spleen, lung, and liver were 
markedly decreased in Nfil3/ mice (Fig. 1 and Table S1). 
Numbers of NK T cells (NK1.1+CD3+) in the same tissues 
were unaffected.
The NK cell abnormality in Nfil3/ mice is the result  
of an intrinsic defect in NK cell progenitors
Murine multipotent progenitors (Kondo et al., 1997) give 
rise to mNK cells in vitro after appropriate cytokine stimula-
tion (Shimozato et al., 2002). We applied an in vitro NK cell 
generation assay to a lineage-negative (Lin) population of 
BM cells. Lin BM cells prepared from WT and Nfil3/ 
mice were stimulated in vitro for 2 wk with a combination of 
murine steel factor (mSlf), murine FMS-like tyrosine kinase 3 
ligand (mFlt3L), and mIL-7, with or without mIL-15. In the 
presence of mIL-15, more than half (57.9 ± 11.8; mean ± SD) 
of WT Lin BM cells became NK1.1+CD3 cells (Fig. 2 A), 
compared with <1% (0.8 ± 0.5%; P = 0.001) of Nfil3/ 
Lin BM cells. To determine whether this defect was specifi-
cally related to the loss of Nfil3, we retrovirally reintroduced 
including control by Ras (via IL-3) in murine B cells (Kuribara 
et al., 1999), thyroid hormone during Xenopus laevis tail   
resorption (Brown et al., 1996; Furlow and Brown, 1999), 
glucocorticoids in murine fibroblasts (Wallace et al., 1997), 
and calcium in rat smooth muscle cells (Nishimura and 
Tanaka, 2001), reflect the many diverse functions that have 
been attributed to this transcription factor. While this manu-
script was under review for publication, E4BP4 was reported 
as being essential for mature NK (mNK) cell development 
(Gascoyne et al., 2009).
In this study, we show that Nfil3 is highly expressed in 
cells of the NK lineage, starting at the immature NK (iNK) 
cell stage. We can confirm that the absence of Nfil3 in 
Nfil3/ mice severely reduces the number of mNK cells 
present in the periphery and that this disturbance in NK cell 
maturation is NK cell intrinsic.
Defects in NK cell development have previously been re-
ported in several gene knockout mice, including those lacking 
genes encoding cytokines or their receptors (for review see 
Boos et al., 2008), downstream targets such as Jak3 (Park   
et al., 1995), or transcription factors such as Ets1 (Barton et al., 
1998), Gata3 (Samson et al., 2003), or Id2 (Boos et al., 2007). 
However, all these mutants also exhibit defects in other 
  hematopoietic cell lineages such as T and NK T cells. Although 
Kim et al. (2000) have described a transgenic mouse model 
with a selective NK cell deficiency, Nfil3/ mice, as de-
scribed by Gascoyne et al. (2009) and ourselves, are currently 
the only gene-targeted animals reported to exhibit an NK 
cell–specific developmental defect.
RESULTS AND DISCUSSION
Gene targeting and characterization of Nfil3 expression
To determine the physiological role of Nfil3, we created Nfil3-
deficient (Nfil3/) mice using conventional gene-targeting 
strategies in embryonic stem (ES) cells, replacing the single Nfil3 
coding exon (exon 2) with the neoR gene cassette (Fig. S1 A). 
Nfil3/ mice were viable and fertile and did not show any 
obvious abnormalities after backcrossing for six generations to 
C57BL/6. We also generated an Nfil3 reporter mouse in which 
to assess Nfil3 expression in normal mouse tissues. We created 
this animal by inserting an IRES -geo cassette (Murakami 
et al., 1997) into exon 2 of the Nfil3 gene (Fig. S1 B). This ap-
proach allowed detection of Nfil3 in tissues of Nfil3+/-IRES 
-geo mice by staining with X-Gal and assaying for -galac-
tosidase activity. Deletion of Nfil3 in Nfil3/ mice was con-
firmed using both Southern (Fig. S1, C and D) and Northern 
(Fig. S1 E) blotting.
To establish the pattern of expression of endogenous Nfil3 
in normal mice, we performed quantitative real-time PCR on 
mouse tissues. Nfil3 was almost ubiquitously expressed and 
was present at relatively high levels in lung, liver, and BM 
(Fig. S2 A, top). In contrast, Nfil3 was low in unfractionated 
spleen. Analysis of messenger RNA (mRNA) levels by RT-
PCR in sorted cell populations revealed low levels of Nfil3 in 
T and B cells but high expression of Nfil3 in elicited perito-
neal macrophages and BM-derived DCs. Up-regulation of JEM VOL. 206, December 21, 2009  2979
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Table I.  Comparison of blood cell parameters in WT and 
Nfil3/ mice
Population Marker and 
parameter
WT Nfil3/
PBMC WBC, ×103/µl 5.97 ± 2.55 7.48 ± 4.53
RBC, ×106/µl 9.06 ± 0.65 8.86 ± 1.83
HGB, g/dl 14.83 ± 0.80 14.49 ± 1.15
HCT, % 52.26 ± 2.97 50.36 ± 7.85
MCV, fL 57.54 ± 2.07 56.68 ± 2.94
MCH, pg 16.34 ± 0.28 16.50 ± 1.19
MCHC, g/dl 28.41 ± 0.68 29.27 ± 3.73
PLT, ×103/µl 1311 ± 150 1279 ± 164
BM lymphocytes, ×107 3.64 ± 1.09 3.49 ± 0.39
B220+CD43+, % 14.28 ± 1.24 13.13 ± 0.76
B220+CD25+, % 17.29 ± 2.76 19.0 ± 1.31
B220+IgM+, % 16.55 ± 3.94 16.41 ± 3.41
Liver lymphocytes, ×107 0.24 ± 0.05 0.23 ± 0.10
Lung lymphocytes, ×107 0.29 ± 0.05 0.34 ± 0.10
Splenocytes, ×107 6.60 ± 0.56 7.14 ± 1.245
B220+CD3, % 48.80 ± 1.22 46.51 ± 5.05
B220+IgM+, % 34.64 ± 9.34 38.54 ± 4.69
B220CD3+, % 33.87 ± 1.86 34.40 ± 3.72
CD8+CD4, % 41.92 ± 1.75 42.33 ± 4.45
CD8CD4+, % 46.57 ± 2.22 45.86 ± 1.11
TCR-+, % 95.33 ± 0.61 95.83 ± 0.44
TCR-+, % 1.43 ± 0.56 1.37 ± 1.23
Thymocytes, ×107 10.68 ± 2.23 10.24 ± 1.21
CD4+CD8, % 9.1 ± 0.20 9.54 ± 1.45
CD4CD8+, % 3.87 ± 0.61 2.94 ± 0.27
CD4+CD8+, % 84.02 ± 1.29 84.48 ± 1.69
CD4CD8, % 3.03 ± 0.58 3.01 ± 0.64
CD25CD44+, % 15.38 ± 4.37 19.05 ± 2.01
CD25+CD44+, % 4.15 ± 1.86 5.17 ± 1.56
CD25+CD44, % 64.13 ± 4.63 62.42 ± 2.02
CD25CD44, % 14.32 ± 2.73 13.31 ± 0.49
Data shown are the mean ± SD of nine independent experiments using mice of 6–8 
wk of age. No significant differences in the indicated cellular distributions were 
observed between WT and Nfil3/ mice (unpaired Student’s t test).
the WT Nfil3 gene into Nfil3/ fetal liver cells (embryonic 
day [E] 13.5) and stimulated the transduced cells in culture 
for 2 wk with mIL-15. Over 35% of the transduced cells gave 
rise to NK1.1-expressing cells (Fig. 2 B, Nfil3 wt). This result 
contrasted dramatically with the lack of NK1.1+ cells gener-
ated from Nfil3/ fetal liver cells transduced with a retrovi-
rus containing an Nfil3 gene lacking its DNA binding domain 
(Fig. 3 B, Nfil3 del) or with cells transduced with empty   
vector. Thus, hematopoietic progenitors cannot carry out 
normal generation of NK cells in the absence of Nfil3.
To assess whether the defect in NK cell development in 
vivo and expansion in vitro was a phenomenon intrinsic to 
NK cell progenitors or was caused by a defect in the micro-
environment of Nfil3/ BM, we performed a mixed chimeric 
BM transfer (BMT). We reconstituted lethally irradiated WT 
or Nfil3/ mice with an equal mix of WT B6.SJL-Ptprc 
Pep3/BoyJ (CD45.1) BM and either WT BM (CD45.2) or 
Nfil3/ BM (CD45.2, backcrossed six times to C57BL/6). 
By 8 wk after BMT, the mix of WT CD45.1 plus WT 
CD45.2 donor cells had repopulated (in equal proportions) 
the NK cell compartments of the spleen, BM, peripheral 
blood (not depicted), and liver (Fig. 2 C) in WT recipients. 
The same pattern of reconstitution was observed in Nfil3/ 
recipients, indicating that a BM microenvironment deficient 
in Nfil3 is fully able to support NK cell development. How-
ever, when WT CD45.1 BM was cotransferred with Nfil3/ 
CD45.2 BM, the Nfil3/ cells were unable to contribute to 
the repopulation of the BM of WT recipients, and the WT 
BM was the source of the vast majority of NK cells present 
(Fig. 2, C–E). This defect in BM reconstitution was NK cell 
specific because Nfil3/ BM was able to support the normal 
repopulation of NK T cells (Fig. 2 C) as well as splenic T, 
BM B, and BM polymorphonuclear neutrophil cells (Fig. 2 D). 
These findings demonstrate that the NK cell abnormality ob-
served in Nfil3/ mice is caused by an intrinsic defect in the 
Nfil3-deficient NK cell progenitors themselves and is not the 
result of an Nfil3-deficient tissue microenvironment.
NK cell development in Nfil3/ mice is disrupted primarily 
at the iNK stage
To dissect in detail the effect of Nfil3 deficiency on NK cell 
development, we evaluated CD122, NKG2D, NK1.1, and 
DX5 expression on NK lineage cells enriched from total   
BM cells of WT and Nfil3/ mice. According to the cur-
rent literature (Kim et al., 2002; Vosshenrich et al., 2005; 
Di Santo, 2006; Huntington et al., 2007; for review see 
Boos et al., 2008), the development of NK lineage cells 
(CD122+NKG2D+ BM cells) progresses through three major   
stages defined by NK1.1 and DX5 expression: NK progeni-
tor (NKP; NK1.1DX5), iNK (NK1.1+DX5), and mNK 
(NK1.1+DX5+) cells. We performed flow cytometric analy-
ses in which CD3CD122+ cells were gated. Because of the 
slightly reduced levels of NKG2D present on Nfil3/ CD122+ 
cells, equivalent populations of CD122+NKG2D+/ cells were 
gated and expression levels of NK1.1 and DX5 were then used 
to determine the developmental maturity of NK lineage cells 
in WT and Nfil3/ BM populations (Fig. 3 A). In the case of 
Nfil3/ CD122+ BM cells, the total number of NKP cells was 
increased (Nfil3/, 1,400.81 ± 383.92; WT, 772.44 ± 62.25; 
P = 0.049), whereas significant reductions had occurred in the 
iNK population (Nfil3/, 405.31 ± 77.32; WT, 1,227.56 ±   
342.55; P = 0.015) and the mNK population (Nfil3/, 
1,995.69 ± 163.94; WT, 6,908.33 ± 373.60; P < 0.001;   
Fig. 3 B, left). These data indicate that NK cell development in 
Nfil3/ mice is impaired before the iNK stage.
Real-time RT-PCR was used to determine the relative 
levels of Nfil3 mRNA in fractionated WT NK cells sorted by 
flow cytometry. In WT BM, Nfil3 expression was higher in 
iNK and mNK cells than in NKP cells or in unfractionated BM 
(Fig. 3 B, right). The apparent block in NK cell development 2980 Nfil3 is essential for NK cell development | Kamizono et al.
hibited lower levels of the activatory receptors 2B4, Ly49D, 
and Nkp46 and the integrin CD11b than did WT controls 
(Fig. 3 D). The mean fluorescence intensities of cells stain-
ing positively for each marker were the following (WT vs. 
Nfil3/): 2B4, 948 versus 694; CD11b, 3,850 versus 3,509; 
CD43,  3,148  versus  4,408;  Ly49D,  7,971  versus  2,750; 
Ly49G2, 5,606 versus 6,932; NKG2A/C/E, 3,945 versus 3,607; 
c-kit, 764 versus 1,224; and NKp46, 2,407 versus 1,430. 
These data confirm the immature nature of the NK lineage 
cells present in Nfil3/ mice.
at the iNK stage therefore corresponds to the relative increase 
in Nfil3 mRNA expressed at this stage compared with the 
NKP stage.
Analysis of proliferation of BM NK cells in vivo was   
assessed via BrdU incorporation. BrDU incorporation was 
comparable between WT and Nfil3/ iNK and mNK cells 
(Fig. 3 C), indicating that proliferation of NK precursors and 
residual mNK cells present in Nfil3/ mice is intact. Flow 
cytometric analysis of a panel of NK cell developmental 
markers revealed that Nfil3/ CD3-CD122+ BM cells ex-
Figure 1.  Nfil3/ mice exhibit defective NK cell populations. (A and B) Representative flow cytometric histograms of NK (A, NK1.1+CD3;  
B, CD122+DX5+) and NK T (NK1.1+CD3+) cells present in the indicated organs from WT and Nfil3/ mice. Percentages of cells in each quadrant are repre-
sentative of three mice analyzed per genotype. (C) Quantification of the percentages (left) and total numbers (right) of lymphocyte-gated NK and NK T 
cells in the indicated organs from WT and Nfil3/ mice. Data shown are the mean ± SEM of three animals analyzed per genotype. NK cell percentages 
and numbers were significantly reduced in Nfil3/ mice. *, P < 0.05; **, P < 0.01. Gating was identical to the FACS profiles shown in A and B.JEM VOL. 206, December 21, 2009  2981
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were stimulated ex vivo with IL-2 plus IL-12, the percentage 
of Nfil3/ NK cells able to produce IFN- was significantly 
decreased compared with the WT in both the BM (Nfil3/, 
33.22 ± 2.95; WT, 59.09 ± 11.44; P = 0.019;) and splenic 
NK cell effector functions are disturbed in Nfil3/ mice
To determine if the immaturity of Nfil3/ NK cells affected 
their functionality, we examined IFN- production by resid-
ual Nfil3/ BM and splenic NK cells. When these NK cells 
Figure 2.  The defect in NK cell development in Nfil3/ mice is NK cell intrinsic. (A) Impaired IL-15–induced in vitro generation of NK cells. Lin BM 
cells from WT or Nfil3/ mice were cultured in medium containing mSlf, mFlt3L, and mIL-7, with or without mIL-15. NK cell expansion was assessed by flow 
cytometry. Results shown are representative of two independent experiments. (B) Rescue by WT Nfil3. Using GFP as a marker for transfected gene expression, 
NK1.1 expression was determined on gated CD3GFP+ (green) or CD3GFP (red) Nfil3/ fetal liver cells (105) that had been retrovirally transduced with 
either the WT Nfil3 gene (wt) or a gene encoding the WT Nfil3 gene lacking its DNA binding domain (deleted [del]). Transduced cells were cultured with mIL-15. 
Numbers indicate the percentage of NK1.1+ cells generated. (C–E) The developmental defect in Nfil3/ mice is NK cell intrinsic. (C) Donor-derived liver NK 
cell populations after BMT showing overall percentages of NK cells (top) and the percentage of CD45.1 and CD45.2 NK cells (bottom). Data shown are repre-
sentative of three mice per group. (D) The ratio of CD45.2/CD45.1 cells in the various indicated lymphoid cell populations after BMT. (E) The absolute numbers 
of CD45.2 and CD45.1 NK cells present in spleen and liver, as calculated from the total cellularity of the lymphoid organs and the percentages of CD45.2 or 
CD45.1 NK1.1+CD3 cells as determined by flow cytometry. Results shown are the mean ± SD for three mice per group.2982 Nfil3 is essential for NK cell development | Kamizono et al.
Figure 3.  Impaired development, maturation, and function of Nfil3/ NK cells. (A) The percentages of cells at each NK developmental stage 
in WT and Nfil3/ BM were determined by flow cytometry. NK lineage cells were gated on BM precursors expressing equivalent levels of CD122. Fig-
ures in quadrants indicate mean percentage ± SD for three mice per group, and dot plots are representative of multiple experiments. (B, Left) Absolute 
numbers of cells at each NK developmental stage in BM (mean ± SD, n = 3 mice/group). Absolute numbers of NK populations were significantly re-
duced in Nfil3/ BM. *, P < 0.05; **, P < 0.01. (B, Right) Real-time RT-PCR analysis of Nfil3 mRNA expression in sorted WT BM cells at each NK devel-
opmental stage. Nfil3 expression was normalized to Gapdh. Data shown are the mean ± SD for triplicate determinations. (C) Proliferation of BM NK 
subsets. The left shows CD3CD122+ gated BM cells (105), analyzed for NK1.1+ (mNK) or NK1.1 (iNK) expression and BrdU incorporation. Numbers in JEM VOL. 206, December 21, 2009  2983
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the molecular pathways underlying the development and sur-
vival of NK cells.
MATERIALS AND METHODS
Gene targeting. A cDNA fragment of murine Nfil3 (GenBank Accession 
no. U83148) was used to screen a bacterial artificial chromosome library 
made from the 129/SvJ mouse strain (Genome Systems). The knockout 
targeting vector was constructed by replacing a 2.2-kb fragment contain-
ing Nfil3 exon 2 with a neomycin resistance cassette. The IRES -geo re-
porter vector was constructed by replacing a 1.7-kb fragment containing 
Nfil3 exon 2 with an IRES -geo promoterless reporter-resistance selec-
tion gene cassette. To create Nfil3/ mice, 20 µg of linearized knockout 
targeting  vector  was  electroporated  into  107  RW4  ES  cells  (129/SvJ;   
Genome Systems) and transfectants were selected 24 h later in 260 µg/ml 
G418 (Sigma-Aldrich) plus 0.2 µM FIAU (Bristol-Myers Squibb). To cre-
ate Nfil3+/-IRES -geo mice, 20 µg of linearized reporter vector was 
electroporated into 107 RW4 ES cells and transfectants were selected 24 h 
later in 200 µg/ml G418. In both cases, transfectants that had undergone 
homologous recombination were identified by Southern blotting. Hetero-
zygous ES clones with a normal karyotype were injected into C57BL/6 
blastocysts, which were subsequently implanted into the uteri of pseudo-
pregnant F1 B/CBA foster mothers and allowed to develop to term. Male 
chimeras (selected by agouti coat color) that carried the mutant allele were 
mated to C57BL/6 females to obtain germline transmission. Disruption of 
the Nfil3 locus in F1 progeny was confirmed by Southern blotting of tail 
DNA, and heterozygous F1 males and females were interbred to generate 
F2 offspring that were backcrossed to C57/Bl6 mice for six generations 
before use in experiments. To generate Nfil3/ ES cells, one Nfil3+/  
ES clone bearing the -geo construct was cultured in increased G418   
(750 µg/ml) for 22 d.
Animals. All mice used in experiments were 6–8 wk old. WT, Nfil3/, 
and  Nfil3+/  IRES  -geo  mice  were  described  in  the  previous  section. 
B6.129P2-2mtm/Unc/J  2  microglobulin-deficient  mice  and  B6.SJL- 
Ptprc Pep3/BoyJ CD45.1 mice were obtained from The Jackson Laboratory. 
All animal experiments were approved by the University Health Network 
Animal Care Committee and performed in accordance with the institutional 
guidelines of the Canadian Council for Animal Care.
X-Gal staining of Nfil3 expression in WT and Nfil3+/-IRES -geo 
mice. X-Gal staining of frozen sections was performed as follows. In brief, 
animals were perfused transcardially at 4°C under deep anesthesia with a 2% 
paraformaldehyde solution in PIPES buffer (34.74 g/liter PIPES disodium 
salt, 0.41 g/liter MgCl2.6H2O, and 0.76 g/liter EGTA, pH 6.9; all chemicals 
were obtained from Sigma-Aldrich unless otherwise stated), post-fixed for 
1 h, dissected, and rinsed overnight in 30% sucrose in PBS. Frozen sections 
were prepared, stained overnight with an X-Gal–containing buffer (1 mg/ml 
(Nfil3/, 33.27 ± 4.14%; WT, 43.44 ± 2.90%; P = 0.025; 
Fig. 3 E) compartments. To assess the cytolytic capacity of 
Nfil3/ residual splenic NK cells, we performed a standard 
in vitro cytolytic assay against Yac-1 target cells. As shown in 
Fig. 3 F, the cytolytic activity of Nfil3/ residual splenic NK 
cells was significantly lower than that of equivalent numbers 
of WT NK cells. In addition, although WT mice were able 
to reject >80% of i.v.-transferred CFSE-labeled 2-micro-
globulin–deficient spleen cells by 24 h after transfer, Nfil3/ 
mice were unable to do so (Fig. 3 G). These results demon-
strate that Nfil3 is required for both the phenotypic and func-
tional maturation of NK cells in both the BM and spleen.   
In particular, the residual NK cells present in Nfil3/ mice 
were unable to eliminate cells that lacked expression of func-
tional MHC class I.
Like the work of Gascoyne et al. (2009), our study dem-
onstrates that mNK cells are markedly reduced in number, 
maturity, and functional capability in the absence of Nfil3 but 
that other hematopoietic cell lineages are not adversely affected. 
We also show that retroviral expression of Nfil3 in murine 
Nfil3/ fetal liver cells is able to restore the development of 
NK1.1-expressing cells and that this activity is dependent on 
the intact DNA binding domain of this transcription factor. 
To our knowledge, aged Nfil3/ mice do not manifest   
increased development of spontaneous cancers or immune 
system disorders (unpublished data). Thus, the absence of NK 
cells does not appear to increase susceptibility to these condi-
tions in mice housed under SPF conditions. Although outside 
of the scope of this brief initial paper, further experiments on 
Nfil3/ mice, such as viral challenge assays, in vivo tumor 
transplantation, and/or crosses with tumor initiation models, 
should prove helpful in elucidating the nonredundant roles of 
NK cells in vivo. The results of such studies may be highly 
significant, especially given the importance of NKG2D in   
immune surveillance (Guerra et al., 2008).
In conclusion, our study shows that Nfil3 is highly   
expressed in cells of the NK cell lineage and promotes the 
development and functional maturation of NK cells. Further 
studies designed to identify the target genes regulated by 
Nfil3 in NK cells, either in an Id2-dependent or -indepen-
dent fashion (Gascoyne et al., 2009), will help to elucidate 
bold indicate the number of cells in each quadrant. The right shows iNK (NK1.1+) or mNK (NK1.1) cells (5 × 103) and histograms for anti-BrdU stain-
ing overlaid. The control histogram was gated on CD3CD122+NK1.1+ cells from an untreated WT mouse. Numbers indicate the percentage of BrdU+ 
cells as specified by the gate. Results are representative of three separate experiments. (D) Developmental markers on BM CD3CD122+ NK cells. BM 
enriched for NK cells was analyzed by flow cytometry. Histogram overlays shown are gated on CD3CD122+NKG2D+ BM cells to include both iNK and 
mNK populations. Red, WT; green, Nfil3/. Numbers indicate percentages of cells within the indicated gates (top). Fluorescence intensity values are 
cited in the text. Data shown are representative of three independent experiments. (E) Impaired NK cell maturation and IFN- production. Left, flow 
cytometric determination of intracellular IFN- production in splenocytes or NK1.1+CD3 BM cells stimulated ex vivo with mIL-2 plus mIL-12. WT, 
green; Nfil3/, red. Filled histograms indicate baseline IFN- production. Right, quantification of the frequencies of CD11b-expressing cells (Mac-1) 
and cells showing intracellular IFN- production (IFN). Data shown are the mean ± SD for three mice per group. (F) Impaired in vitro cytolytic activity. 
Yac-1 cell lysis by poly I:C–activated NK1.1+CD3 splenocytes from WT and Nfil3/ mice was compared. The E/T ratio (2 × 104 Yac-1 cells/well) was 
analyzed after 4 h of co-culture. For E and F, data are the mean ± SEM of triplicate experiments. *, P < 0.05; **, P < 0.01. (G) Impaired rejection in vivo. 
WT and Nfil3/ mice received CFSE-labeled 2-microglobulin–deficient and WT splenocytes, and preferential killing of the MHC class I–deficient tar-
gets in spleen (SPL) and liver (LIV) was examined by flow cytometry. NK cells from Nfil3/ mice failed to reject the donated cells. Data shown are 
representative of two independent experiments.
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Hiroshima, Japan) were subcloned in MSCV-ires-GFP and transfected into 
Phoenix packaging cells (G. Nolan, Stanford University, Stanford, CA). The 
retrovirus-containing supernatant was precoated on RetroNection-coated 
six-well plates (Cambrex), and the cytokine-stimulated fetal liver cells were 
cultured in these plates in the presence of 50 ng/ml mSlf, 50 ng/ml mFlt3L, 
5 ng/ml mIL-7, and 20 ng/ml mIL-15.
Lin BM cell preparation. Lin BM cells were prepared using the IMag 
NK cell enrichment kit (BD). LinCD34+ BM cells did not express CD3, 
CD19, Gr-1, Mac-1, or Ter119.
Adoptive cell transfer. WT and Nfil3/ recipients were irradiated with 
6Gy on days 0 and 1. On day 2, the mice were transplanted i.v. with 5 × 106 
B6.SJL-Ptprc Pep3/BoyJ (CD45.1) BM cells mixed equally with 5 × 106 
C57BL/6 WT (CD45.2) or Nfil3/ (CD45.2) BM cells. A 1:1 ratio of 
CD45.1/CD45.2 cells was confirmed by flow cytometry before injection. 
At 8 wk after transfer, blood, spleen, BM, and liver were harvested and single 
cell suspensions prepared. Liver mononuclear cells were isolated using Per-
coll  density  gradients.  After  erythrocyte  lysis,  lymphoid  cell  populations 
were counted and NK, polymorphonuclear neutrophil, B, and T cell num-
bers were assessed by flow cytometry using mAbs against NK1.1, TCR-, 
B220, CD11b, Gr-1, CD45.1, or CD45.2.
In vivo proliferation of BM NK cells. WT (n = 2) and Nfil3/ (n = 4) 
mice were fed 0.8 mg/ml BrdU orally in drinking water for 3 d. Pooled BM 
was depleted of TER119+, CD19+, CD3+, CD4+, CD8+, and Gr-1+ cells 
using the iMag magnetic bead system (BD), and the remaining cells were 
stained  with  mAbs  against  CD3,  CD122,  or  NK1.1.  Proliferation  of 
CD3CD122+ cells was determined using the APC BrdU flow cytometry 
kit (BD) according to the manufacturer’s instructions.
IFN- production in NK cells. 106 enriched NK cells from BM and 
spleen were incubated with 50 ng/ml mIL-2 plus 50 ng/ml mIL-12 (both 
from R&D Systems) for 12 h, treated with 1 µl/ml GolgiPlug (BD), and 
cultured for an additional 4 h with IL-2 and IL-12. IFN- production was 
assessed by intracellular flow cytometry (Prussin and Metcalfe, 1995).
In vitro NK cytotoxicity assay. Mice were injected i.p. with 150 µg poly 
I:C 16 h before sacrifice, and NK cytotoxicity was analyzed in FACS-sorted 
NK1.1+CD3 splenocytes using a flow cytometric method as previously de-
scribed (Souza et al., 2001).
In vivo NK cytotoxicity assay. WT or Nfil3/ recipients were injected 
i.p. with 200 µg poly I:C. After 24 h, 30 × 106 spleen cells, consisting of an 
equal mix of differentially CFSE-labeled C57BL/6 (0.5 µM) and B6.129P2-
2mtm/Unc/J (5 µM) spleen cells, were transferred i.v. into the recipients. 
After 24 h, spleen and liver mononuclear cells were isolated and examined 
by flow cytometry. The percent killing of differentially labeled donor cells 
was calculated as follows: % killing = [1(%2m/ CFSEhi × %C57BL/6 
CFSElo)/(%C57BL/6 CFSElo × %2m/ CFSEhi)] × 100.
Statistical analysis. An unpaired Student’s t test was used to determine the 
significance of differences between the means of parameters measured in 
WT and Nfil3/ mice.
T  cell  activation  assay. Splenic T cells purified by negative selection 
(Imag streptavidin particles; BD) were left untreated or stimulated for 24 h 
in plates coated with anti-CD3 (145-2C11; BD) plus anti-CD28 (37.51; 
BD) or in plates containing 20 ng/ml PMA plus 100 ng/ml ionomycin   
(both from Sigma-Aldrich). Recovered cells were immunostained with   
antibodies against CD25, CD44, and CD69 and activation was assessed by 
flow cytometry.
T and B cell proliferation assay. Purified splenic T cells were stimulated 
for 48 h in plates coated with 1 µg/ml of anti-CD3 and/or anti-CD28 
X-Gal [5-bromo-4-chloro-3-indolyl--d-galactopyranoside]; GIBCO BRL) 
predissolved in DMF (N,N-dimethylformamide; 0.65 g/400 ml potassium 
ferricyanide, 0.84 g/400 ml potassium ferrocyanide.3H2O, 0.16 g/400 ml 
MgCl2.6H2O, 80 µl/400 ml Nonidet P-40, and 0.04 g/400 ml sodium   
deoxycholate), and counterstained with eosin-y for 10 s.
Detection of Nfil3 gene expression in NKPs and mouse tissues. 
NKPs (at least 1.5 × 104 cells per developmental stage) were sorted from BM 
cells of 60 WT mice. cDNA for real-time RT-PCR was prepared using   
the Advantage RT-for-PCR kit (Takara Bio Inc.), and total mRNA was 
isolated using the RNeasy mini kit (QIAGEN). Real-time RT-PCR assays 
to detect Nfil3 and Gapdh were performed in triplicate using the 7900HT 
Sequence Detection System and Taqman assays (Applied Biosystems). RNA 
from tissues was prepared using the RNeasy mini kit and cDNA was pre-
pared using the iScript cDNA kit (Bio-Rad Laboratories). Real-time RT-
PCR was performed as described in this section but using SYBR green 
reagent (Applied Biosystems).
Primers for real-time PCR. The primers Mm00600292-s1 for Nfil3 and 
Mm99999915-g1 for Gapdh were premade by Applied Biosystems. The   
parameter threshold cycle (Ct) is defined as the fractional cycle number at 
which the fluorescence generated by cleavage of the probe exceeds a fixed 
threshold above baseline.
Blood and lymphoid cell preparation. Peripheral blood cells were ob-
tained from the femoral arteries of 6-wk-old WT and Nfil3/ mice. Blood 
was analyzed using an automated complete blood cell counter (Coulter 
counter for mice; model ATVIA #120; Bayer). Single cell suspensions of 
  total splenocytes and thymocytes were obtained by passing organs through 
70-µm cell strainers (BD), followed by treatment with red blood cell (RBC) 
lysis  buffer  (Sigma-Aldrich).  Lymphocytes  from  BM  were  isolated  from 
  femurs and tibias and also treated with RBC lysis buffer. Mononuclear 
  lymphocytes from homogenized liver and lung were recovered from the 
  interface of a 70%/40% Percoll centrifugation gradient (Amersham Bio-
sciences). Live lymphocyte counts were performed using an automated cell 
viability analyzer (Vi-cell XR 2.03; Beckman Coulter).
Antibodies. Cells from murine lymphoid tissues were analyzed using mAbs 
recognizing the following: NK1.1 (clone PK136), CD3 (17A2), CD49b 
(DX5), CD122 (TM-1), NKG2D (CX5), CD11b (M1/70), CD117 (2B8), 
2B4  (2B4),  CD43  (S7),  Ly49D  (4E5),  Ly49G2  (Cwy-3),  Ly49C  (5E6), 
NKG2A/C/E (20d5), NKp46 (29A1.4), CD45.1 (A20), CD45.2 (104), or 
IFN- (XMG1.2). All antibodies, except for anti-NKG2D (FITC conju-
gated [BioLegend] and APC conjugated [eBioscience]) and CD3 eFluor780 
and NKp46 eFluor710 (eBioscience), were purchased from BD. Antibodies 
were incubated with cells for 15 min at 4°C after blocking with purified 
anti-CD16/CD32 mAb (2.4G).
Flow cytometric analysis. Single cell suspensions from BM, spleen, 
liver, and lung were incubated with mouse mAbs recognizing specific 
markers. Cells were analyzed using FACSCalibur or Canto flow cytome-
ters (BD) and FlowJo software (Tree Star, Inc.). NK and NK T popula-
tions  were  quantified  based  on  lymphocyte  gating  of  total  lymphoid 
organ populations.
IL-15–induced in vitro generation of NK cells. Lin BM cells (105) 
were cultured for 2 wk with 50 ng/ml mSlf, 50 ng/ml mFlt3L, and 5 ng/ml 
mIL-7, with or without 20 ng/ml mIL-15 (all cytokines were obtained from 
R&D Systems).
Retroviral Nfil3 expression in fetal liver cells. Fetal liver cells from 
E13.5 Nfil3/ embryos were cultured in 20% FCS, 100 mg/ml mSlf,   
250 mg/ml mFlt3L, and 50 ng/ml mTPO as previously described (Pellegrini 
et al., 2005). The WT Nfil3 gene and Nfil3 lacking its DNA binding domain 
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